{"gene":"HCN4","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2011,"finding":"Cardiac-specific inducible knockout of HCN4 in adult mice causes ~70% reduction in If current and ~60% reduction in spontaneous sinoatrial node rate, leading to severe bradycardia (~50% rate reduction), AV block, and death, demonstrating that HCN4 channels are essential for normal cardiac impulse generation and conduction.","method":"Inducible cardiac-specific knockout mouse model, patch-clamp electrophysiology on isolated SAN myocytes, immunofluorescence, Western blot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — clean cardiac-specific KO with defined electrophysiological and phenotypic readouts, multiple orthogonal methods","pmids":["21220308"],"is_preprint":false},{"year":2003,"finding":"HCN4 and HCN1 co-assemble into heteromeric channels in the rabbit sinoatrial node; HCN4-HCN1 tandem constructs show intermediate activation kinetics between the two homomeric channels, suggesting native If reflects heteromeric HCN4/HCN1 channels with properties distinct from either isoform alone.","method":"Heterologous expression in HEK293 cells, patch-clamp electrophysiology, concatenated tandem constructs, co-transfection","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution of heteromeric channels with functional validation; replicated across multiple construct designs","pmids":["12702747"],"is_preprint":false},{"year":2001,"finding":"HCN1 and HCN4 are expressed in a subset of taste receptor cells; lowering extracellular pH causes a dose-dependent depolarizing shift in the activation curve of HCN channels, indicating that HCN4 channels are gated by extracellular protons and may function as sour taste receptors.","method":"In situ hybridization, immunohistochemistry, patch-clamp electrophysiology on taste cells, pH dose-response","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — direct electrophysiological recordings with pH manipulation, replicated with immunohistochemistry and in situ hybridization","pmids":["11675786"],"is_preprint":false},{"year":2004,"finding":"The D553N missense mutation in HCN4 causes a trafficking defect that reduces membrane expression of the channel in a dominant-negative manner, resulting in decreased If current and sinus node dysfunction.","method":"Heterologous expression in HEK293 cells, patch-clamp electrophysiology, Western blot, trafficking assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — functional expression with dominant-negative co-expression, trafficking assay, multiple methods in a single study","pmids":["15123648"],"is_preprint":false},{"year":2003,"finding":"KCNE2 specifically co-assembles with HCN4 (but not other KCNE family members) via interaction of its C-terminal tail with the C-terminal tail of HCN4, enhancing current amplitude and slowing activation kinetics of HCN4 channels.","method":"Heterologous expression in Xenopus oocytes and CHO cells, two-electrode voltage-clamp, patch-clamp, yeast two-hybrid assay","journal":"Pflugers Archiv : European journal of physiology","confidence":"High","confidence_rationale":"Tier 1-2 — functional co-expression combined with yeast two-hybrid protein interaction, specific isoform selectivity demonstrated","pmids":["12856183"],"is_preprint":false},{"year":2010,"finding":"The crystal structure of the C-terminal fragment of human HCN4 (C-linker + CNBD) at 2.4 Å reveals high overall similarity to mouse HCN2 but shows a ~3-fold reduced response to cAMP; residues in the β4-β5 loop region account for isoform differences in cAMP sensitivity. Upon cAMP binding, hHCN4 C-terminal protein exerts a prolonged effect on channel deactivation.","method":"X-ray crystallography, biochemistry, patch-clamp electrophysiology, mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mutagenesis and functional validation in a single study","pmids":["20829353"],"is_preprint":false},{"year":2010,"finding":"PKA directly phosphorylates HCN4 at ≥13 sites (identified by in vitro phosphorylation and mass spectrometry), including a regulatory site in the distal C-terminus required for PKA-mediated shift of voltage dependence. PKA inhibition reduces β-adrenergic modulation of If in sinoatrial myocytes, indicating PKA phosphorylation contributes independently to sympathetic regulation of heart rate.","method":"In vitro phosphorylation assay, mass spectrometry, patch-clamp on isolated sinoatrial myocytes, HCN4 truncation and alanine-substitution mutants in HEK cells","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 — in vitro phosphorylation + MS site identification + mutagenesis + native cell electrophysiology in one study","pmids":["20713547"],"is_preprint":false},{"year":2007,"finding":"The G480R mutation in the HCN4 pore domain causes familial sinus bradycardia by activating channels at more negative voltages and reducing channel synthesis and plasma membrane trafficking, demonstrated by biotinylation and Western blot.","method":"Expression in Xenopus oocytes and HEK293 cells, patch-clamp, biotinylation assay, Western blot","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (electrophysiology + trafficking/biotinylation) in single study","pmids":["17646576"],"is_preprint":false},{"year":2003,"finding":"Residues in transmembrane segments S1, the S1-S2 linker, and S2 of HCN4 determine its slow activation kinetics relative to HCN2; L272 in S1 is the dominant determinant, and I308M in S2 abolishes cAMP-dependent acceleration of activation kinetics.","method":"Chimeric channel analysis (HCN2/4 chimeras and point mutants), patch-clamp electrophysiology","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with systematic chimera analysis and functional validation","pmids":["12813043"],"is_preprint":false},{"year":2006,"finding":"Constitutively active Src tyrosine kinase enhances HCN4 activity (positive voltage shift, accelerated kinetics, increased conductance) and forms a direct protein complex with HCN4, as shown by co-immunoprecipitation in HEK293 cells and rat ventricular myocytes.","method":"Co-transfection in HEK293 cells, whole-cell patch-clamp, co-immunoprecipitation","journal":"Journal of cardiovascular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP plus functional electrophysiology, single lab","pmids":["16680072"],"is_preprint":false},{"year":2007,"finding":"Src tyrosine kinase modulates HCN4 gating primarily through Tyr531; the Y531F mutation abolishes Src-mediated positive voltage shift and conductance increase of HCN4 channels. Tyr554 mediates Src-dependent kinetic changes but not voltage dependence.","method":"Selective Src inhibitor (PP2), site-directed mutagenesis, whole-cell patch-clamp in HEK293 cells and HL-1 cardiomyocytes, in vivo mouse heart rate measurement","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis identifying specific tyrosine residues with functional electrophysiological validation","pmids":["17977941"],"is_preprint":false},{"year":2012,"finding":"HCN4 contains a conserved caveolin-binding domain (CBD) composed of aromatic residues Y259 and F262 at the N-terminus; disruption of the CBD reduces HCN4 current density, weakens HCN4-caveolin-1 interaction, causes cytoplasmic channel accumulation, and abolishes sensitivity to cholesterol depletion-induced caveolar disorganization.","method":"Mutagenesis (Y259S, F262V, Y259F, F262Y), patch-clamp in CHO cells and caveolin-1-free fibroblasts, co-immunoprecipitation","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis + functional electrophysiology + protein interaction, multiple cell types","pmids":["22659290"],"is_preprint":false},{"year":2012,"finding":"β2-adrenergic receptors form a direct protein complex with HCN4 channels; the binding site is located at a proximal region of the HCN4 N-terminal tail. A synthetic peptide from this region disrupts the HCN4-β2AR complex and prevents adrenergic augmentation of If and spontaneous contraction rate, but does not affect adrenergic regulation of voltage-gated calcium currents.","method":"Co-immunoprecipitation, synthetic peptide competition, patch-clamp electrophysiology, spontaneous contraction rate measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — Co-IP + peptide disruption + functional electrophysiology, defining binding domain","pmids":["22613709"],"is_preprint":false},{"year":2012,"finding":"HCN4 K530N mutation in the C-linker causes tachycardia-bradycardia syndrome and atrial fibrillation; in heteromeric channels (WT+mutant), but not homomeric mutant channels, there is a significant hyperpolarizing shift in half-maximal activation voltage, attributed to altered C-linker oligomerization equilibrium between nucleotide-free and ligand-bound tetrameric states.","method":"Patch-clamp electrophysiology in HEK293 cells (homomeric and heteromeric co-expression), pedigree analysis","journal":"European heart journal","confidence":"Medium","confidence_rationale":"Tier 2-3 — heteromeric co-expression with functional analysis, single lab","pmids":["23178648"],"is_preprint":false},{"year":2009,"finding":"Cardiac myocardial HCN2 undergoes proteolytic processing in adult mouse heart, losing its C-terminal cAMP-binding domain to yield a ~60 kDa fragment; this C-terminally truncated HCN2 co-assembles with HCN4 to form heteromeric channels that activate faster than homomeric HCN2 or HCN4 and display properties similar to endogenous myocardial If. HCN4 provides the cAMP sensitivity in these complexes.","method":"Western blot, co-immunoprecipitation with isoform-specific antibodies from adult mouse heart, heterologous expression of truncated HCN2+HCN4, patch-clamp","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — co-IP from native tissue + reconstituted heteromeric channels + functional electrophysiology","pmids":["19574228"],"is_preprint":false},{"year":2009,"finding":"MEF2 (myocyte enhancer factor-2) and AP1 transcription factors directly bind to the CNS13 enhancer in the Hcn4 genomic locus; dominant-negative MEF2 inhibits enhancer activity, reduces Hcn4 mRNA expression, and decreases Ih amplitude in embryonic heart inflow tract myocytes, establishing Hcn4 as a direct MEF2 transcriptional target.","method":"Luciferase reporter assay, EMSA, chromatin immunoprecipitation, dominant-negative MEF2 overexpression, patch-clamp in primary neonatal rat cardiomyocytes","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP + EMSA + functional electrophysiology confirming transcriptional mechanism","pmids":["19477969"],"is_preprint":false},{"year":2006,"finding":"The NRSE motif in the HCN4 gene promoter binds NRSF (neuron-restrictive silencing factor), and this interaction mediates the developmental silencing of HCN4 after birth and its reactivation during cardiac hypertrophy; mutant NRSE constructs fail to recapitulate developmental expression changes.","method":"Promoter-luciferase reporter assay, EMSA confirming NRSF binding, mutation analysis in primary neonatal rat cardiomyocytes","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — EMSA + reporter assay, single lab","pmids":["17173866"],"is_preprint":false},{"year":2008,"finding":"HCN4 is a direct target of miR-1 in cardiomyocytes; down-regulation of miR-1 in hypertrophied rat hearts contributes to increased HCN4 protein levels, and forced miR-1 expression prevents HCN4 overexpression in hypertrophic cardiomyocytes.","method":"Western blot, RT-PCR, transfection of miR-1 mimics in primary neonatal cardiomyocytes, rat cardiac hypertrophy model","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional miRNA over-expression experiments with protein readout, single lab","pmids":["18458081"],"is_preprint":false},{"year":2017,"finding":"miR-423-5p targets the HCN4 3'-UTR and suppresses HCN4 expression; knockdown of miR-423-5p rescues HCN4 expression and If, reversing training-induced bradycardia in swim-trained mice. The upregulation of miR-423-5p and its host gene NSRP1 in the sinus node is driven by increased Nkx2.5.","method":"Luciferase 3'-UTR reporter assay, anti-miR knockdown in vivo, next-generation sequencing, qRT-PCR, Western blot, patch-clamp, chromatin immunoprecipitation","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1-2 — reporter assay + anti-miR in vivo rescue + ChIP + functional electrophysiology, multiple orthogonal methods","pmids":["28821541"],"is_preprint":false},{"year":2020,"finding":"The circadian clock transcription factor BMAL1 directly binds to the Hcn4 promoter in sinoatrial node cells, driving 24-hour rhythmicity of HCN4 expression and If. Cardiomyocyte-specific knockout of Bmal1 abolishes the day-night difference in Hcn4 mRNA expression and intrinsic heart rate.","method":"Chromatin immunoprecipitation, cardiomyocyte-specific Bmal1 KO transgenic mice, patch-clamp, qRT-PCR, Western blot, telemetric ECG, HCN4 promoter reporter bioluminescence","journal":"Heart rhythm","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP identifying BMAL1 binding + KO rescue + functional electrophysiology, multiple orthogonal methods","pmids":["33278629"],"is_preprint":false},{"year":2012,"finding":"Mef2C directly activates an Hcn4 enhancer in non-chamber myocardium and the postnatal AV bundle in a Mef2c-dependent manner in vivo; HDAC inhibition expands Hcn4 enhancer activity to working myocardium, and cardiac hypertrophy-induced HDAC nuclear export causes ectopic Hcn4 enhancer activation in working myocardium.","method":"Transgenic reporter mice, in vivo cis-regulatory analysis, HDAC inhibitor treatment of transgenic embryos, transverse aortic constriction model","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo transgenic enhancer assay + Mef2c dependence + HDAC manipulation, single lab","pmids":["23085412"],"is_preprint":false},{"year":2019,"finding":"Mitochondrial thioredoxin-2 (Trx2) maintains HCN4 expression in sinoatrial node cells; its deletion increases mitochondrial ROS, which elevates HDAC4, reduces histone acetylation at the MEF2 binding site of the HCN4 enhancer, and decreases HCN4 transcription, causing sick sinus syndrome.","method":"Cardiac conduction system-specific Trx2 KO (Hcn4-CreERT2), chromatin immunoprecipitation, histological analysis, mitochondria-specific ROS scavenger (MitoTEMPO) rescue, ECG telemetry","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 — conduction system-specific KO + ChIP + pharmacological rescue, multiple orthogonal methods identifying HDAC4-MEF2C pathway","pmids":["31751569"],"is_preprint":false},{"year":2020,"finding":"Ectopic HCN4 expression in cortical FCM neurons (driven by mTOR hyperactivation) is sufficient to cause epileptic seizures; increasing intracellular cAMP (which preferentially enhances HCN4 gating) drives repetitive firing selectively in FCM neurons, and blocking HCN4 prevents epilepsy in the mouse model.","method":"Mouse FCM model (TSC/FCDII), patch-clamp, cAMP manipulation, HCN4 channel blockade, immunohistochemistry in human resected tissue","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 1-2 — loss-of-function block prevents epilepsy + gain-of-function cAMP drives firing + validated in human tissue","pmids":["33208499"],"is_preprint":false},{"year":2012,"finding":"HCN4 cAMP sensitivity and basal voltage dependence are controlled by multiple channel domains, including the distal C-terminus (residues 719-1012); in CHO cells, ligand-independent relief of autoinhibition occurs for HCN4 but not HCN2, mediated by membrane-associated intracellular factors acting on the distal C-terminus.","method":"Patch-clamp in CHO and HEK cells, excised patch recordings, truncation mutants, isoform comparison","journal":"The Journal of general physiology","confidence":"Medium","confidence_rationale":"Tier 1-2 — domain truncation + excised patch ruling out soluble factors + cell-type comparison, single lab","pmids":["23109717"],"is_preprint":false},{"year":2020,"finding":"LRMP (Jaw1) and IRAG (Mrvi1/Jaw1L) are ER transmembrane proteins that associate with and modulate HCN4 in an isoform-specific manner: LRMP inhibits cAMP-dependent activation of HCN4 while IRAG causes ligand-independent depolarization of basal voltage dependence. IRAG is highly expressed in mouse sinoatrial node and computer modeling predicts it increases HCN4 current.","method":"Co-immunoprecipitation, patch-clamp in HEK and CHO cells, computer modeling, mouse sinoatrial node expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — Co-IP + isoform-specific functional electrophysiology + native tissue expression + computer modeling, multiple orthogonal methods","pmids":["32647060"],"is_preprint":false},{"year":2021,"finding":"Shugoshin-1 directly interacts with HCN4 to promote cell-surface expression and function; the clinical CAID syndrome mutation p.Lys23Glu impairs this interaction, reducing funny-current and causing dysrhythmia in patient-derived iPSC-cardiomyocytes.","method":"Co-immunoprecipitation, patch-clamp in neonatal rat ventricular myocytes and iPSC-cardiomyocytes, surface expression assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — direct protein interaction + functional electrophysiology + patient-derived cells + disease-causing mutation validation","pmids":["33953173"],"is_preprint":false},{"year":2011,"finding":"HCN4 channels contain two tissue-specific N-terminal variants arising from different transcription start sites; the brain expresses only one variant while heart expresses both. Three positively charged residues (Arg9, Lys10, Lys22) in the N-terminus contribute to differential channel activation kinetics between variants.","method":"Identification of mRNA variants, patch-clamp in HEK293H cells, N-terminal mutagenesis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1-2 — mutagenesis + electrophysiology, single lab, novel splice variant with functional consequence","pmids":["21372143"],"is_preprint":false},{"year":2010,"finding":"Human HCN4 exhibits voltage-dependent hysteresis: the activation curve shifts to more depolarized voltages with more hyperpolarized holding potentials. cAMP enhances If and modifies this intrinsic hysteresis. HCN4 accounts for 75% of HCN transcripts in human sinoatrial node.","method":"Patch-clamp in HEK293 cells stably expressing hHCN4 (triangular ramp and action potential clamp protocols), qRT-PCR of human SAN tissue","journal":"Sheng li xue bao : [Acta physiologica Sinica]","confidence":"Medium","confidence_rationale":"Tier 2 — direct electrophysiology with multiple clamp protocols + human SAN qPCR, single lab","pmids":["20179882"],"is_preprint":false},{"year":2018,"finding":"HCN4 pacemaker channels attenuate parasympathetic (vagal) responses of the sinoatrial node: HCN4 knockdown enhances parasympathetic-induced sinus pause, while HCN4 overexpression attenuates bradycardia induced by vagus nerve stimulation during β-adrenergic stimulation. β-adrenergic response of the SAN is preserved regardless of HCN4 expression level.","method":"Tetracycline-inducible HCN4 overexpression/knockdown transgenic mice, telemetric ECG, vagus nerve stimulation, patch-clamp on isolated pacemaker cells","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — reversible gain and loss-of-function transgenics + direct vagus nerve stimulation + patch-clamp, multiple orthogonal readouts","pmids":["29315578"],"is_preprint":false},{"year":2024,"finding":"Cryo-EM structure of HCN4 in complex with ivabradine at 3 Å resolution shows ivabradine bound inside the open pore; Y507 and I511 on S6 are the key molecular determinants of ivabradine binding to the inner cavity, F510 indirectly contributes by controlling Y507 orientation, and Cys479 in the selectivity filter accelerates the kinetics of block. Molecular dynamics simulations show ivabradine blocks ion permeation by electrostatic repulsion at the selectivity filter.","method":"Cryo-EM structure determination, molecular dynamics simulations, electrophysiology","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure at 3 Å + MD simulations identifying blocking mechanism, rigorous structural study","pmids":["38917012"],"is_preprint":false},{"year":2012,"finding":"The HCN4 D553N mutation in the C-linker causes a gating defect rather than a primary trafficking defect: D553N channels reach the plasma membrane normally but generate currents with reduced amplitude, likely due to stabilization of a salt bridge important for C-linker gating. cAMP regulation is altered but not sufficient to account for the full loss-of-function.","method":"Fluorescence microscopy, FACS surface expression assay, two-electrode voltage-clamp in Xenopus oocytes, patch-clamp in mammalian cells","journal":"Cellular physiology and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple electrophysiological and surface expression methods, revises prior trafficking interpretation","pmids":["23075627"],"is_preprint":false},{"year":2009,"finding":"Sp1 is a common transactivator of HCN4 gene transcription; siRNA silencing of Sp1 prevents overexpression of HCN4 in hypertrophic cardiomyocytes, and upregulation of Sp1 underlies pathological re-expression of HCN4 in ventricular hypertrophy.","method":"5'-RACE, luciferase reporter assay, qRT-PCR, Western blot, Sp1 siRNA knockdown in primary neonatal rat cardiomyocytes","journal":"Cellular physiology and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — promoter analysis + siRNA knockdown with functional readout, single lab","pmids":["19471099"],"is_preprint":false},{"year":2013,"finding":"HCN4 co-localizes and co-immunoprecipitates with caveolin-3 in adult human atrial and ventricular cardiomyocytes; caveolae disruption shifts the voltage dependence of If toward more positive (immature) values in adult cardiomyocytes but not in fetal cardiomyocytes where HCN4-Cav3 co-localization is absent.","method":"Co-immunoprecipitation, immunohistochemistry in hESC-CMs and adult/fetal human cardiomyocytes, patch-clamp with caveolae-disrupting agents","journal":"Stem cells and development","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP + functional electrophysiology + developmental stage comparison, single lab","pmids":["23311301"],"is_preprint":false},{"year":2012,"finding":"Thy1 (a GPI-anchored protein) co-localizes and co-immunoprecipitates with HCN4 in rat retinal ganglion cells, representing the first reported association of Thy1 with a membrane-spanning ion channel subunit.","method":"Co-immunoprecipitation with anti-Thy1 and anti-HCN4 antibodies, immunohistochemistry, confocal imaging, patch-clamp on immunopanned cells","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2-3 — reciprocal Co-IP + electrophysiology, single lab","pmids":["22281825"],"is_preprint":false},{"year":2023,"finding":"A gain-of-function HCN4 mutation V240M located in the N-terminal HCN domain increases single-channel conductance, opening frequency, and opening probability without altering cAMP sensitivity or membrane expression, causing inappropriate sinus tachycardia. Computer simulations confirm increased If and beating rate. Treatment with ivabradine reversed IST and cardiomyopathy.","method":"Macroscopic and single-channel patch-clamp in cells expressing WT and/or V240M HCN4, computer simulations, clinical ivabradine treatment","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — single-channel recordings + macroscopic currents + computer modeling + clinical validation, multiple orthogonal methods","pmids":["38032931"],"is_preprint":false},{"year":2022,"finding":"CVB3 (Coxsackievirus B3) reduces HCN4 plasma membrane density in hiPSC-derived pacemaker cells by triggering increased autophagosomal insertion of HCN4; CVB3 non-structural proteins 2C and 3A have the most robust effect on HCN4 activity. Inhibition of Rab7-directed autophagosome transport (with CID 106770) recovers cytoplasmic HCN4 accumulation.","method":"hiPSC-derived pacemaker cells with inducible CVB3 expression, HCN4 trafficking immunofluorescence, patch-clamp, HEK cell HCN4 expression system, Rab7 and CVB3-3A inhibitors","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional viral protein analysis + trafficking assay + pharmacological rescue, single lab","pmids":["35864219"],"is_preprint":false},{"year":2021,"finding":"LncRNA RCPCD suppresses HCN4 expression by increasing methylation of the HCN4 promoter through DNMT1, DNMT2, and DNMT3; overexpression of RCPCD inhibits differentiation of embryonic stem cells into pacemaker-like cells, an effect rescued by HCN4 co-expression.","method":"Methylation-specific PCR, chromatin immunoprecipitation, RNA immunoprecipitation, luciferase reporter, adenoviral overexpression/knockdown, rescue experiments","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 — methylation-specific PCR + ChIP + functional rescue, multiple methods but single lab","pmids":["34215719"],"is_preprint":false},{"year":2013,"finding":"Testosterone recruits the androgen receptor (AR) directly to regulatory regions of the HCN4 gene (and MEF2C), increasing histone acetylation and upregulating HCN4 expression and cardiomyogenesis in stem cells.","method":"Chromatin immunoprecipitation, AR knockdown/antagonist, dose-response, qRT-PCR, Western blot in mES and P19 cells","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP identifying AR binding at HCN4 locus + loss-of-function knockdown, single lab","pmids":["23598283"],"is_preprint":false}],"current_model":"HCN4 is the principal pore-forming subunit of cardiac and neuronal hyperpolarization-activated cyclic nucleotide-gated (If/Ih) channels: it forms homo- or heterotetramers (e.g., with HCN1 or proteolytically processed HCN2) localized in caveolae via a caveolin-binding domain, is gated by membrane hyperpolarization and potentiated by direct cAMP binding to its C-terminal CNBD (with the C-linker controlling gating), is additionally phosphorylated by PKA at ≥13 sites (including a distal C-terminal regulatory site) to mediate β-adrenergic rate acceleration, is further modulated by Src kinase phosphorylation (at Tyr531), forms signaling complexes with β2-adrenergic receptors (via the N-terminal tail), LRMP, IRAG, and Shugoshin-1, and its transcription is directly controlled by MEF2, NRSF, Sp1, BMAL1 (circadian clock), HDAC4, miR-1, and miR-423-5p, with ivabradine blocking the open pore at Y507/I511 on S6 as revealed by cryo-EM."},"narrative":{"teleology":[{"year":2001,"claim":"Demonstrating that HCN4 channels in taste receptor cells are gated by extracellular protons expanded HCN4 function beyond cardiac pacemaking to sensory transduction.","evidence":"Patch-clamp on taste cells with pH manipulation, in situ hybridization and immunohistochemistry","pmids":["11675786"],"confidence":"High","gaps":["Whether HCN4 is required for sour taste in vivo was not tested","Contribution relative to other acid-sensing channels in taste cells unknown"]},{"year":2003,"claim":"Establishing that HCN4 co-assembles with HCN1 into heteromeric channels with intermediate kinetics resolved how native If properties differ from any single HCN isoform.","evidence":"Tandem concatenated HCN4-HCN1 constructs and co-transfection in HEK293 cells with patch-clamp","pmids":["12702747"],"confidence":"High","gaps":["Stoichiometry of native heteromeric channels in SAN not determined","Whether other HCN isoforms participate in native complexes unclear"]},{"year":2003,"claim":"Chimeric HCN2/HCN4 analysis identified L272 in S1 and I308 in S2 as determinants of HCN4's characteristically slow activation and cAMP-dependent kinetic modulation, localizing gating control to the voltage-sensor domain.","evidence":"Systematic chimera and point-mutant electrophysiology in heterologous cells","pmids":["12813043"],"confidence":"High","gaps":["Structural basis of how L272 slows gating not resolved","Interaction between S1-S2 region and C-linker/CNBD gating not addressed"]},{"year":2003,"claim":"Identifying KCNE2 as a specific auxiliary subunit of HCN4 that enhances current amplitude and slows kinetics revealed a β-subunit modulation mechanism for pacemaker channels.","evidence":"Co-expression in oocytes and CHO cells, yeast two-hybrid mapping interaction to C-terminal tails","pmids":["12856183"],"confidence":"High","gaps":["In vivo relevance of KCNE2-HCN4 interaction in SAN not demonstrated","Whether KCNE2 participates in native heteromeric HCN4/HCN1 channels unknown"]},{"year":2004,"claim":"The D553N mutation was initially shown to cause dominant-negative trafficking failure, establishing the first disease mechanism for HCN4 channelopathy causing sinus node dysfunction.","evidence":"Trafficking and electrophysiology assays in HEK293 cells with WT/mutant co-expression","pmids":["15123648"],"confidence":"High","gaps":["Later work (PMID:23075627) revised the mechanism to a gating defect rather than trafficking failure","No in vivo knock-in model"]},{"year":2006,"claim":"Discovery that NRSF binds the HCN4 promoter NRSE motif explained the developmental silencing of HCN4 after birth and its pathological re-expression during cardiac hypertrophy.","evidence":"EMSA and luciferase reporter assays with NRSE mutations in neonatal rat cardiomyocytes","pmids":["17173866"],"confidence":"Medium","gaps":["No ChIP confirmation of NRSF binding in vivo","Mechanism of NRSF de-repression in hypertrophy not fully defined"]},{"year":2006,"claim":"Src kinase was identified as a direct modulator of HCN4, forming a protein complex and enhancing channel activity, adding tyrosine kinase signaling to the regulatory repertoire of pacemaker channels.","evidence":"Co-immunoprecipitation and patch-clamp in HEK293 cells and rat ventricular myocytes with constitutively active Src","pmids":["16680072"],"confidence":"Medium","gaps":["Specific phosphorylation sites not identified in this study","Physiological stimulus activating Src-HCN4 pathway in SAN not established"]},{"year":2007,"claim":"Mapping Tyr531 as the critical Src phosphosite for voltage-dependent modulation of HCN4, and separately showing G480R causes familial bradycardia via pore-domain trafficking and gating defects, established residue-level mechanisms for kinase regulation and a second disease-causing mutation.","evidence":"Y531F mutagenesis with PP2 inhibitor and patch-clamp (PMID:17977941); G480R biotinylation and electrophysiology in oocytes/HEK cells (PMID:17646576)","pmids":["17977941","17646576"],"confidence":"High","gaps":["Whether Src phosphorylation of Y531 occurs in native SAN pacemaker cells not confirmed","Structural consequence of G480R on pore architecture unknown"]},{"year":2008,"claim":"Identifying miR-1 as a direct post-transcriptional repressor of HCN4 linked microRNA dysregulation to arrhythmogenic HCN4 overexpression in cardiac hypertrophy.","evidence":"miR-1 mimic transfection preventing HCN4 protein increase in hypertrophic neonatal cardiomyocytes","pmids":["18458081"],"confidence":"Medium","gaps":["Direct 3′-UTR targeting by miR-1 not validated by reporter assay in this study","In vivo rescue with miR-1 not performed"]},{"year":2009,"claim":"Three discoveries converged to define transcriptional and heterotetrameric control: MEF2 directly activates HCN4 transcription via the CNS13 enhancer, Sp1 drives pathological HCN4 re-expression in hypertrophy, and proteolytically processed HCN2 co-assembles with HCN4 providing the cAMP sensor in native cardiac If.","evidence":"ChIP/EMSA/dominant-negative MEF2 in cardiomyocytes (PMID:19477969); Sp1 siRNA in hypertrophic cardiomyocytes (PMID:19471099); Co-IP from native heart tissue + reconstituted truncated-HCN2/HCN4 heteromers (PMID:19574228)","pmids":["19477969","19471099","19574228"],"confidence":"High","gaps":["Whether HCN2 proteolysis occurs in human heart not shown","Integration of MEF2 and Sp1 transcriptional pathways not defined"]},{"year":2010,"claim":"The crystal structure of the HCN4 C-linker/CNBD revealed that the β4–β5 loop accounts for HCN4's reduced cAMP sensitivity relative to HCN2, while PKA phosphoproteomics identified ≥13 sites including a distal C-terminal site required for β-adrenergic If modulation, establishing dual (direct cAMP + PKA phosphorylation) sympathetic control.","evidence":"2.4 Å X-ray crystallography with mutagenesis (PMID:20829353); in vitro phosphorylation/MS + SAN patch-clamp with PKA inhibition (PMID:20713547)","pmids":["20829353","20713547"],"confidence":"High","gaps":["Full-length HCN4 structure not available at this time","How PKA phosphorylation and cAMP binding interact allosterically within the tetramer not resolved"]},{"year":2011,"claim":"Cardiac-specific HCN4 knockout proved the channel is essential for normal impulse generation, causing ~50% rate reduction, AV block, and lethality, definitively establishing HCN4 as the dominant If contributor in the adult heart.","evidence":"Inducible cardiac-specific KO mice with SAN patch-clamp and ECG","pmids":["21220308"],"confidence":"High","gaps":["Relative contributions of HCN4 loss-of-function to SAN arrest versus AV block not fully dissected","Whether residual If in KO reflects HCN1 or HCN2 contribution not determined"]},{"year":2012,"claim":"Multiple discoveries defined the macromolecular signaling complex: HCN4 localizes to caveolae via Y259/F262, β2-adrenergic receptors bind the HCN4 N-terminal tail to enable local adrenergic modulation, and Mef2c/HDAC-dependent enhancer regulation controls tissue-specific HCN4 expression.","evidence":"Caveolin-binding domain mutagenesis + Co-IP (PMID:22659290); β2AR-HCN4 Co-IP + peptide disruption (PMID:22613709); transgenic enhancer mice + HDAC inhibitor (PMID:23085412)","pmids":["22659290","22613709","23085412"],"confidence":"High","gaps":["Whether β2AR-HCN4 complex exists in native SAN tissue not shown by Co-IP from tissue","HDAC isoform specificity in enhancer regulation not fully resolved"]},{"year":2012,"claim":"The D553N mechanism was revised from trafficking defect to C-linker gating defect, and the K530N C-linker mutation was linked to tachycardia-bradycardia syndrome, establishing the C-linker as a critical disease-relevant gating element.","evidence":"Surface expression assays showing normal D553N trafficking (PMID:23075627); heteromeric WT+K530N electrophysiology and pedigree (PMID:23178648)","pmids":["23075627","23178648"],"confidence":"Medium","gaps":["No structural data on how D553N or K530N alter C-linker conformation","K530N heteromeric mechanism based on single-family pedigree"]},{"year":2017,"claim":"miR-423-5p was identified as a physiological repressor of HCN4 in the SAN, mediating exercise-induced bradycardia through an Nkx2.5-driven pathway, with in vivo anti-miR rescue restoring HCN4 and heart rate.","evidence":"3′-UTR reporter + anti-miR in swim-trained mice + ChIP for Nkx2.5 + patch-clamp","pmids":["28821541"],"confidence":"High","gaps":["Long-term effects of anti-miR-423-5p on cardiac function not assessed","Whether this pathway operates in human athletes unknown"]},{"year":2018,"claim":"Bidirectional transgenic experiments showed HCN4 primarily buffers parasympathetic (vagal) slowing of heart rate rather than mediating sympathetic acceleration, reframing the physiological role of If in autonomic regulation.","evidence":"Inducible HCN4 overexpression/knockdown mice with vagus nerve stimulation and telemetric ECG","pmids":["29315578"],"confidence":"High","gaps":["Whether vagal buffering is the dominant in vivo role during all physiological states not tested","Contribution of other ion channels to this vagal buffering not excluded"]},{"year":2019,"claim":"The Trx2-ROS-HDAC4-MEF2 axis was identified as a redox-sensitive pathway controlling HCN4 transcription: mitochondrial ROS elevation activates HDAC4 to suppress MEF2-dependent HCN4 enhancer, causing sick sinus syndrome.","evidence":"Conduction system-specific Trx2 KO mice, ChIP, MitoTEMPO rescue, ECG telemetry","pmids":["31751569"],"confidence":"High","gaps":["Whether this redox pathway operates in human SAN disease not established","Direct HDAC4 phosphorylation/activation mechanism by ROS not defined"]},{"year":2020,"claim":"LRMP and IRAG were identified as ER-tethered, isoform-specific modulators of HCN4—LRMP inhibiting cAMP-dependent gating and IRAG causing ligand-independent voltage shift—while BMAL1 was shown to directly drive circadian HCN4 transcription in the SAN.","evidence":"Co-IP + patch-clamp for LRMP/IRAG (PMID:32647060); ChIP + Bmal1 cardiomyocyte-KO + promoter bioluminescence (PMID:33278629)","pmids":["32647060","33278629"],"confidence":"High","gaps":["How ER-resident LRMP/IRAG access plasma membrane HCN4 mechanistically unclear","Whether BMAL1 rhythmicity is disrupted in human SAN disease not tested"]},{"year":2020,"claim":"Ectopic HCN4 expression driven by mTOR hyperactivation was shown sufficient to cause epileptic seizures in cortical malformation neurons, establishing a pathogenic neuronal role for HCN4 outside the heart.","evidence":"Mouse FCM model with HCN4 blockade preventing seizures, validated in resected human tissue","pmids":["33208499"],"confidence":"High","gaps":["Whether HCN4-selective blockers would be effective anti-epileptic drugs in humans not tested","Mechanism of mTOR-driven HCN4 transcription not defined"]},{"year":2021,"claim":"Shugoshin-1 was identified as a trafficking partner of HCN4, with the CAID syndrome mutation impairing this interaction and reducing If in patient iPSC-cardiomyocytes, linking a mitotic regulator to pacemaker channel surface expression.","evidence":"Co-IP, surface expression assay, patch-clamp in iPSC-CMs carrying the SGO1 K23E mutation","pmids":["33953173"],"confidence":"High","gaps":["Structural basis of SGO1-HCN4 interaction unknown","Whether SGO1 regulates HCN4 in SAN tissue in vivo not shown"]},{"year":2023,"claim":"Single-channel recordings of the V240M gain-of-function mutation showed increased conductance and open probability causing inappropriate sinus tachycardia, the first HCN4 gain-of-function mechanism resolved at single-channel level, with ivabradine providing clinical rescue.","evidence":"Single-channel and macroscopic patch-clamp, computer simulations, clinical ivabradine treatment","pmids":["38032931"],"confidence":"High","gaps":["Structural mechanism by which V240M in the HCN domain increases conductance unknown","Long-term outcomes of ivabradine in HCN4 gain-of-function patients not reported"]},{"year":2024,"claim":"The 3 Å cryo-EM structure of HCN4 bound to ivabradine revealed the drug's open-pore binding site at Y507/I511 on S6 and the role of C479 in block kinetics, providing the first near-atomic view of HCN4 pharmacological inhibition.","evidence":"Cryo-EM structure determination, molecular dynamics simulations, electrophysiology with pore mutants","pmids":["38917012"],"confidence":"High","gaps":["Structure in the closed or cAMP-free state not yet reported","Whether ivabradine binding differs in heteromeric HCN4/HCN1 channels unknown"]},{"year":null,"claim":"A full-length, state-resolved structural model of HCN4 in its resting, open, and cAMP-bound conformations—particularly in heteromeric complexes with HCN1—remains unavailable, limiting mechanistic understanding of voltage-dependent gating, hysteresis, and allosteric coupling between the CNBD, C-linker, and voltage sensor.","evidence":"","pmids":[],"confidence":"High","gaps":["No full-length structure of HCN4 in the closed/resting state","Heteromeric HCN4/HCN1 channel architecture not structurally resolved","Integration of PKA phosphorylation, Src phosphorylation, and cAMP binding within the native tetramer not mechanistically modeled"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,5,6,8,27,29]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[2,5,27]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,7,11,25,29,32,34]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,9,10,12,28]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,22]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[15,16,18,19,20,31]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,3,7,13,34]}],"complexes":["HCN4/HCN1 heterotetramer","HCN4/HCN2 heterotetramer","HCN4-β2AR signaling complex"],"partners":["HCN1","HCN2","KCNE2","CAV1","CAV3","ADRB2","LRMP","SGO1"],"other_free_text":[]},"mechanistic_narrative":"HCN4 is the principal pore-forming subunit of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels that generate the cardiac pacemaker current (If/Ih), and it is essential for sinoatrial node automaticity, atrioventricular conduction, and autonomic heart rate regulation. HCN4 forms homotetramers or heterotetramers with HCN1 or proteolytically processed HCN2, is gated by membrane hyperpolarization with kinetics determined by S1–S2 transmembrane residues (notably L272), and is potentiated by direct cAMP binding to its C-terminal CNBD—whose isoform-specific sensitivity is set by the β4–β5 loop—while PKA phosphorylation at ≥13 sites and Src kinase phosphorylation at Tyr531 provide additional sympathetic modulation [PMID:20829353, PMID:20713547, PMID:17977941, PMID:12813043]. Channel surface expression requires a caveolin-binding domain (Y259/F262) that targets HCN4 to caveolae, and is further regulated by protein partners including β2-adrenergic receptors (via the N-terminal tail), LRMP, IRAG, and Shugoshin-1, while transcription is controlled by MEF2, NRSF, Sp1, BMAL1 (circadian rhythmicity), HDAC4, miR-1, and miR-423-5p [PMID:22659290, PMID:22613709, PMID:32647060, PMID:33953173, PMID:19477969, PMID:33278629, PMID:28821541]. Loss-of-function mutations (e.g., D553N, G480R) cause familial sinus bradycardia and sick sinus syndrome, while the gain-of-function V240M mutation causes inappropriate sinus tachycardia treatable with ivabradine, which blocks the open pore at Y507/I511 on S6 as revealed by cryo-EM [PMID:15123648, PMID:17646576, PMID:38032931, PMID:38917012]."},"prefetch_data":{"uniprot":{"accession":"Q9Y3Q4","full_name":"Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","aliases":[],"length_aa":1203,"mass_kda":129.0,"function":"Hyperpolarization-activated ion channel that are permeable to Na(+) and K(+) ions with very slow activation and inactivation (PubMed:10228147, PubMed:10430953, PubMed:20829353). Exhibits higher selectivity for K(+) over Na(+) ions (PubMed:10228147). Contributes to the native pacemaker currents in heart (If) that regulate the rhythm of heart beat (Probable) (PubMed:10228147, PubMed:16407510, PubMed:19165230). Contributes to the native pacemaker currents in neurons (Ih) (Probable). May mediate responses to sour stimuli (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q9Y3Q4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HCN4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HCN4","total_profiled":1310},"omim":[{"mim_id":"619521","title":"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 18; EIG18","url":"https://www.omim.org/entry/619521"},{"mim_id":"613123","title":"BRUGADA SYNDROME 8; BRGDA8","url":"https://www.omim.org/entry/613123"},{"mim_id":"608567","title":"SICK SINUS SYNDROME 1; SSS1","url":"https://www.omim.org/entry/608567"},{"mim_id":"605206","title":"HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 4; HCN4","url":"https://www.omim.org/entry/605206"},{"mim_id":"602780","title":"HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 1; HCN1","url":"https://www.omim.org/entry/602780"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"heart muscle","ntpm":8.2},{"tissue":"testis","ntpm":7.0}],"url":"https://www.proteinatlas.org/search/HCN4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9Y3Q4","domains":[{"cath_id":"-","chopping":"213-409","consensus_level":"medium","plddt":86.0334,"start":213,"end":409},{"cath_id":"1.10.287,1.10.287","chopping":"410-521","consensus_level":"medium","plddt":92.1818,"start":410,"end":521},{"cath_id":"2.60.120.10","chopping":"587-763","consensus_level":"high","plddt":86.6703,"start":587,"end":763}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y3Q4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y3Q4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y3Q4-F1-predicted_aligned_error_v6.png","plddt_mean":59.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HCN4","jax_strain_url":"https://www.jax.org/strain/search?query=HCN4"},"sequence":{"accession":"Q9Y3Q4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y3Q4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y3Q4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y3Q4"}},"corpus_meta":[{"pmid":"21220308","id":"PMC_21220308","title":"Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21220308","citation_count":228,"is_preprint":false},{"pmid":"23743334","id":"PMC_23743334","title":"HCN4 dynamically marks the first heart field and conduction system precursors.","date":"2013","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/23743334","citation_count":178,"is_preprint":false},{"pmid":"12702747","id":"PMC_12702747","title":"Heteromeric HCN1-HCN4 channels: a comparison with native pacemaker channels from the rabbit sinoatrial node.","date":"2003","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12702747","citation_count":178,"is_preprint":false},{"pmid":"11675786","id":"PMC_11675786","title":"Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli.","date":"2001","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11675786","citation_count":172,"is_preprint":false},{"pmid":"15123648","id":"PMC_15123648","title":"Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15123648","citation_count":162,"is_preprint":false},{"pmid":"17516552","id":"PMC_17516552","title":"Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4.","date":"2007","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17516552","citation_count":149,"is_preprint":false},{"pmid":"23974038","id":"PMC_23974038","title":"A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells.","date":"2013","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23974038","citation_count":148,"is_preprint":false},{"pmid":"18458081","id":"PMC_18458081","title":"Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18458081","citation_count":147,"is_preprint":false},{"pmid":"25145517","id":"PMC_25145517","title":"HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy.","date":"2014","source":"Journal of the American College of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25145517","citation_count":145,"is_preprint":false},{"pmid":"17646576","id":"PMC_17646576","title":"Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia.","date":"2007","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/17646576","citation_count":121,"is_preprint":false},{"pmid":"25145518","id":"PMC_25145518","title":"The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel.","date":"2014","source":"Journal of the American College of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25145518","citation_count":112,"is_preprint":false},{"pmid":"16989793","id":"PMC_16989793","title":"Extended atrial conduction system characterised by the expression of the HCN4 channel and connexin45.","date":"2006","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/16989793","citation_count":90,"is_preprint":false},{"pmid":"14643687","id":"PMC_14643687","title":"Expression of the hyperpolarization-activated cyclic nucleotide-gated cation channel HCN4 during mouse heart development.","date":"2003","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/14643687","citation_count":89,"is_preprint":false},{"pmid":"12856183","id":"PMC_12856183","title":"KCNE2 modulates current amplitudes and activation kinetics of HCN4: influence of KCNE family members on HCN4 currents.","date":"2003","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12856183","citation_count":85,"is_preprint":false},{"pmid":"25642760","id":"PMC_25642760","title":"Pacemaker activity of the human sinoatrial node: an update on the effects of mutations in HCN4 on the hyperpolarization-activated current.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25642760","citation_count":83,"is_preprint":false},{"pmid":"20829353","id":"PMC_20829353","title":"Structural basis for the cAMP-dependent gating in the human HCN4 channel.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20829353","citation_count":81,"is_preprint":false},{"pmid":"20713547","id":"PMC_20713547","title":"Phosphorylation and modulation of hyperpolarization-activated HCN4 channels by protein kinase A in the mouse sinoatrial node.","date":"2010","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20713547","citation_count":80,"is_preprint":false},{"pmid":"23178648","id":"PMC_23178648","title":"Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation.","date":"2012","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/23178648","citation_count":76,"is_preprint":false},{"pmid":"28821541","id":"PMC_28821541","title":"Targeting miR-423-5p Reverses Exercise Training-Induced HCN4 Channel Remodeling and Sinus Bradycardia.","date":"2017","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/28821541","citation_count":71,"is_preprint":false},{"pmid":"19165230","id":"PMC_19165230","title":"Role of HCN4 channel in preventing ventricular arrhythmia.","date":"2009","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19165230","citation_count":66,"is_preprint":false},{"pmid":"19394343","id":"PMC_19394343","title":"Distribution of the pacemaker HCN4 channel mRNA and protein in the rabbit sinoatrial node.","date":"2009","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/19394343","citation_count":65,"is_preprint":false},{"pmid":"33278629","id":"PMC_33278629","title":"A circadian clock in the sinus node mediates day-night rhythms in Hcn4 and heart rate.","date":"2020","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/33278629","citation_count":62,"is_preprint":false},{"pmid":"25986146","id":"PMC_25986146","title":"Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4.","date":"2015","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25986146","citation_count":57,"is_preprint":false},{"pmid":"24607718","id":"PMC_24607718","title":"A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation.","date":"2014","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/24607718","citation_count":55,"is_preprint":false},{"pmid":"20662977","id":"PMC_20662977","title":"A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in Moroccan Jews.","date":"2010","source":"Journal of cardiovascular electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/20662977","citation_count":53,"is_preprint":false},{"pmid":"22659290","id":"PMC_22659290","title":"A caveolin-binding domain in the HCN4 channels mediates functional interaction with caveolin proteins.","date":"2012","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/22659290","citation_count":50,"is_preprint":false},{"pmid":"12813043","id":"PMC_12813043","title":"Molecular basis for the different activation kinetics of the pacemaker channels HCN2 and HCN4.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12813043","citation_count":48,"is_preprint":false},{"pmid":"26835093","id":"PMC_26835093","title":"HCN4, Sinus Bradycardia and Atrial Fibrillation.","date":"2015","source":"Arrhythmia & electrophysiology review","url":"https://pubmed.ncbi.nlm.nih.gov/26835093","citation_count":46,"is_preprint":false},{"pmid":"23357121","id":"PMC_23357121","title":"HCN4 subunit expression in fast-spiking interneurons of the rat spinal cord and hippocampus.","date":"2013","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23357121","citation_count":46,"is_preprint":false},{"pmid":"33208499","id":"PMC_33208499","title":"Ectopic HCN4 expression drives mTOR-dependent epilepsy in mice.","date":"2020","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33208499","citation_count":42,"is_preprint":false},{"pmid":"17977941","id":"PMC_17977941","title":"Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17977941","citation_count":39,"is_preprint":false},{"pmid":"21421080","id":"PMC_21421080","title":"Funny current channel HCN4 delineates the developing cardiac conduction system in chicken heart.","date":"2011","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/21421080","citation_count":38,"is_preprint":false},{"pmid":"28104484","id":"PMC_28104484","title":"Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction.","date":"2017","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/28104484","citation_count":37,"is_preprint":false},{"pmid":"16680072","id":"PMC_16680072","title":"Constitutively active Src tyrosine kinase changes gating of HCN4 channels through direct binding to the channel proteins.","date":"2006","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16680072","citation_count":37,"is_preprint":false},{"pmid":"24569893","id":"PMC_24569893","title":"Pacemaker activity of the human sinoatrial node: effects of HCN4 mutations on the hyperpolarization-activated current.","date":"2014","source":"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/24569893","citation_count":36,"is_preprint":false},{"pmid":"19477969","id":"PMC_19477969","title":"The cardiac pacemaker-specific channel Hcn4 is a direct transcriptional target of MEF2.","date":"2009","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/19477969","citation_count":36,"is_preprint":false},{"pmid":"17173866","id":"PMC_17173866","title":"NRSF regulates the developmental and hypertrophic changes of HCN4 transcription in rat cardiac myocytes.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17173866","citation_count":35,"is_preprint":false},{"pmid":"23311301","id":"PMC_23311301","title":"Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.","date":"2013","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/23311301","citation_count":34,"is_preprint":false},{"pmid":"26384234","id":"PMC_26384234","title":"Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26384234","citation_count":34,"is_preprint":false},{"pmid":"30127718","id":"PMC_30127718","title":"A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability.","date":"2018","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30127718","citation_count":32,"is_preprint":false},{"pmid":"29315578","id":"PMC_29315578","title":"HCN4 pacemaker channels attenuate the parasympathetic response and stabilize the spontaneous firing of the sinoatrial node.","date":"2018","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29315578","citation_count":31,"is_preprint":false},{"pmid":"28871229","id":"PMC_28871229","title":"Gabapentin Modulates HCN4 Channel Voltage-Dependence.","date":"2017","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28871229","citation_count":28,"is_preprint":false},{"pmid":"17382969","id":"PMC_17382969","title":"Adenoviral gene transfer of HCN4 creates a genetic pacemaker in pigs with complete atrioventricular block.","date":"2007","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17382969","citation_count":28,"is_preprint":false},{"pmid":"18383475","id":"PMC_18383475","title":"Engineering physiologically controlled pacemaker cells with lentiviral HCN4 gene transfer.","date":"2008","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18383475","citation_count":28,"is_preprint":false},{"pmid":"23085412","id":"PMC_23085412","title":"Spatiotemporal regulation of an Hcn4 enhancer defines a role for Mef2c and HDACs in cardiac electrical patterning.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23085412","citation_count":26,"is_preprint":false},{"pmid":"29588962","id":"PMC_29588962","title":"Functional variants in HCN4 and CACNA1H may contribute to genetic generalized epilepsy.","date":"2017","source":"Epilepsia open","url":"https://pubmed.ncbi.nlm.nih.gov/29588962","citation_count":25,"is_preprint":false},{"pmid":"20381460","id":"PMC_20381460","title":"Dynamic changes in HCN2, HCN4, KCNE1, and KCNE2 expression in ventricular cells from acute myocardial infarction rat hearts.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20381460","citation_count":25,"is_preprint":false},{"pmid":"25442735","id":"PMC_25442735","title":"Insights into cardiac conduction system formation provided by HCN4 expression.","date":"2014","source":"Trends in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25442735","citation_count":24,"is_preprint":false},{"pmid":"27553229","id":"PMC_27553229","title":"Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.","date":"2016","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27553229","citation_count":24,"is_preprint":false},{"pmid":"19820968","id":"PMC_19820968","title":"Hyperpolarization-activated cyclic-nucleotide gated 4 (HCN4) protein is expressed in a subset of rat dorsal root and trigeminal ganglion neurons.","date":"2009","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/19820968","citation_count":24,"is_preprint":false},{"pmid":"30585408","id":"PMC_30585408","title":"HCN4 knockdown in dorsal hippocampus promotes anxiety-like behavior in mice.","date":"2019","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/30585408","citation_count":23,"is_preprint":false},{"pmid":"23598283","id":"PMC_23598283","title":"Testosterone enhances cardiomyogenesis in stem cells and recruits the androgen receptor to the MEF2C and HCN4 genes.","date":"2013","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23598283","citation_count":22,"is_preprint":false},{"pmid":"19574228","id":"PMC_19574228","title":"Proteolytic processing of HCN2 and co-assembly with HCN4 in the generation of cardiac pacemaker channels.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19574228","citation_count":21,"is_preprint":false},{"pmid":"20179882","id":"PMC_20179882","title":"Hysteresis in human HCN4 channels: a crucial feature potentially affecting sinoatrial node pacemaking.","date":"2010","source":"Sheng li xue bao : [Acta physiologica Sinica]","url":"https://pubmed.ncbi.nlm.nih.gov/20179882","citation_count":21,"is_preprint":false},{"pmid":"24492017","id":"PMC_24492017","title":"A novel HCN4 mutation, G1097W, is associated with atrioventricular block.","date":"2014","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/24492017","citation_count":20,"is_preprint":false},{"pmid":"21529705","id":"PMC_21529705","title":"Association of polymorphisms in HCN4 with mood disorders and obsessive compulsive disorder.","date":"2011","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/21529705","citation_count":20,"is_preprint":false},{"pmid":"19471099","id":"PMC_19471099","title":"Transcriptional control of pacemaker channel genes HCN2 and HCN4 by Sp1 and implications in re-expression of these genes in hypertrophied myocytes.","date":"2009","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19471099","citation_count":20,"is_preprint":false},{"pmid":"23109717","id":"PMC_23109717","title":"Cellular context and multiple channel domains determine cAMP sensitivity of HCN4 channels: ligand-independent relief of autoinhibition in HCN4.","date":"2012","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23109717","citation_count":19,"is_preprint":false},{"pmid":"32647060","id":"PMC_32647060","title":"Isoform-specific regulation of HCN4 channels by a family of endoplasmic reticulum proteins.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32647060","citation_count":18,"is_preprint":false},{"pmid":"22613709","id":"PMC_22613709","title":"Adrenergic regulation of HCN4 channel requires protein association with β2-adrenergic receptor.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22613709","citation_count":18,"is_preprint":false},{"pmid":"31555092","id":"PMC_31555092","title":"Using a Multiplex Nucleic Acid in situ Hybridization Technique to Determine HCN4 mRNA Expression in the Adult Rodent Brain.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31555092","citation_count":18,"is_preprint":false},{"pmid":"31751569","id":"PMC_31751569","title":"Mitochondrial thioredoxin-2 maintains HCN4 expression and prevents oxidative stress-mediated sick sinus syndrome.","date":"2019","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/31751569","citation_count":17,"is_preprint":false},{"pmid":"38032931","id":"PMC_38032931","title":"A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38032931","citation_count":17,"is_preprint":false},{"pmid":"19895411","id":"PMC_19895411","title":"Identification, isolation and characterization of HCN4-positive pacemaking cells derived from murine embryonic stem cells during cardiac differentiation.","date":"2009","source":"Pacing and clinical electrophysiology : PACE","url":"https://pubmed.ncbi.nlm.nih.gov/19895411","citation_count":17,"is_preprint":false},{"pmid":"32130893","id":"PMC_32130893","title":"Gastrointestinal Neurons Expressing HCN4 Regulate Retrograde Peristalsis.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32130893","citation_count":16,"is_preprint":false},{"pmid":"26206080","id":"PMC_26206080","title":"HCN4 mutation as a molecular explanation on patients with bradycardia and non-compaction cardiomyopathy.","date":"2015","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26206080","citation_count":16,"is_preprint":false},{"pmid":"35556164","id":"PMC_35556164","title":"Paradigm shift: new concepts for HCN4 function in cardiac pacemaking.","date":"2022","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35556164","citation_count":15,"is_preprint":false},{"pmid":"29349559","id":"PMC_29349559","title":"A mutant HCN4 channel in a family with bradycardia, left bundle branch block, and left ventricular noncompaction.","date":"2018","source":"Heart and vessels","url":"https://pubmed.ncbi.nlm.nih.gov/29349559","citation_count":15,"is_preprint":false},{"pmid":"35328031","id":"PMC_35328031","title":"Clinical Presentation of Left Ventricular Noncompaction Cardiomyopathy and Bradycardia in Three Families Carrying HCN4 Pathogenic Variants.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35328031","citation_count":14,"is_preprint":false},{"pmid":"31481236","id":"PMC_31481236","title":"The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart disease.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31481236","citation_count":14,"is_preprint":false},{"pmid":"29987112","id":"PMC_29987112","title":"HCN4 Gene Polymorphisms Are Associated With Occurrence of Tachycardia-Induced Cardiomyopathy in Patients With Atrial Fibrillation.","date":"2018","source":"Circulation. Genomic and precision medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29987112","citation_count":14,"is_preprint":false},{"pmid":"33953173","id":"PMC_33953173","title":"Cohesin-protein Shugoshin-1 controls cardiac automaticity via HCN4 pacemaker channel.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33953173","citation_count":13,"is_preprint":false},{"pmid":"30196304","id":"PMC_30196304","title":"In Vitro Analyses of Novel HCN4 Gene Mutations.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30196304","citation_count":13,"is_preprint":false},{"pmid":"22683190","id":"PMC_22683190","title":"Hyperpolarisation-activated cyclic nucleotide channel 4 (HCN4) involvement in Tourette's syndrome autoimmunity.","date":"2012","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/22683190","citation_count":13,"is_preprint":false},{"pmid":"23768927","id":"PMC_23768927","title":"In situ investigation of allografted mouse HCN4 gene-transfected rat bone marrow mesenchymal stromal cells with the use of patch-clamp recording of ventricular slices.","date":"2013","source":"Cytotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/23768927","citation_count":13,"is_preprint":false},{"pmid":"24281837","id":"PMC_24281837","title":"Inducible gene deletion in the entire cardiac conduction system using Hcn4-CreERT2 BAC transgenic mice.","date":"2013","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/24281837","citation_count":12,"is_preprint":false},{"pmid":"28465117","id":"PMC_28465117","title":"A novel 'splice site' HCN4 Gene mutation, c.1737+1 G>T, causes familial bradycardia, reduced heart rate response, impaired chronotropic competence and increased short-term heart rate variability.","date":"2017","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/28465117","citation_count":12,"is_preprint":false},{"pmid":"32234357","id":"PMC_32234357","title":"Notch1-mediated histone demethylation of HCN4 contributes to aconitine-induced ventricular myocardial dysrhythmia.","date":"2020","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32234357","citation_count":11,"is_preprint":false},{"pmid":"29628472","id":"PMC_29628472","title":"HCN4-Overexpressing Mouse Embryonic Stem Cell-Derived Cardiomyocytes Generate a New Rapid Rhythm in Rats with Bradycardia.","date":"2018","source":"International heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/29628472","citation_count":11,"is_preprint":false},{"pmid":"31291594","id":"PMC_31291594","title":"Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells.","date":"2019","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31291594","citation_count":10,"is_preprint":false},{"pmid":"35864219","id":"PMC_35864219","title":"Virus-induced inhibition of cardiac pacemaker channel HCN4 triggers bradycardia in human-induced stem cell system.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/35864219","citation_count":10,"is_preprint":false},{"pmid":"34215719","id":"PMC_34215719","title":"Downregulated lncRNA RCPCD promotes differentiation of embryonic stem cells into cardiac pacemaker-like cells by suppressing HCN4 promoter methylation.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34215719","citation_count":10,"is_preprint":false},{"pmid":"22281825","id":"PMC_22281825","title":"Thy1 associates with the cation channel subunit HCN4 in adult rat retina.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22281825","citation_count":10,"is_preprint":false},{"pmid":"18282314","id":"PMC_18282314","title":"HCN4-like immunoreactivity in rat retinal ganglion cells.","date":"2008","source":"Visual neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18282314","citation_count":10,"is_preprint":false},{"pmid":"38917012","id":"PMC_38917012","title":"Structural determinants of ivabradine block of the open pore of HCN4.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38917012","citation_count":9,"is_preprint":false},{"pmid":"20207172","id":"PMC_20207172","title":"Expression of hyperpolarization-activated cyclic nucleotide-gated cation channel (HCN4) is increased in hypertrophic cardiomyopathy.","date":"2010","source":"Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20207172","citation_count":9,"is_preprint":false},{"pmid":"30794847","id":"PMC_30794847","title":"Protein and surface expression of HCN2 and HCN4 subunits in mesocorticolimbic areas after cocaine sensitization.","date":"2019","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/30794847","citation_count":9,"is_preprint":false},{"pmid":"22107837","id":"PMC_22107837","title":"Blocking effects of acehytisine on pacemaker currents (I(f)) in sinoatrial node cells and human HCN4 channels expressed in Xenopus laevis oocytes.","date":"2011","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22107837","citation_count":9,"is_preprint":false},{"pmid":"35365232","id":"PMC_35365232","title":"Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35365232","citation_count":8,"is_preprint":false},{"pmid":"23075627","id":"PMC_23075627","title":"The HCN4 channel mutation D553N associated with bradycardia has a C-linker mediated gating defect.","date":"2012","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23075627","citation_count":8,"is_preprint":false},{"pmid":"21372143","id":"PMC_21372143","title":"Tissue-specific N terminus of the HCN4 channel affects channel activation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21372143","citation_count":8,"is_preprint":false},{"pmid":"33450487","id":"PMC_33450487","title":"Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression.","date":"2021","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/33450487","citation_count":8,"is_preprint":false},{"pmid":"37523352","id":"PMC_37523352","title":"Alkali metal cations modulate the geometry of different binding sites in HCN4 selectivity filter for permeation or block.","date":"2023","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37523352","citation_count":8,"is_preprint":false},{"pmid":"26550270","id":"PMC_26550270","title":"Morphology of mouse sinoatrial node and its expression of NF-160 and HCN4.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26550270","citation_count":7,"is_preprint":false},{"pmid":"37879946","id":"PMC_37879946","title":"Electroacupuncture inhibits PDK1/Akt/HCN4 pathway to improve neurogenic urinary retention in rats.","date":"2023","source":"Zhen ci yan jiu = Acupuncture research","url":"https://pubmed.ncbi.nlm.nih.gov/37879946","citation_count":6,"is_preprint":false},{"pmid":"31315459","id":"PMC_31315459","title":"Correlation between HCN4 gene polymorphisms and lone atrial fibrillation risk.","date":"2019","source":"Artificial cells, nanomedicine, and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31315459","citation_count":5,"is_preprint":false},{"pmid":"32948209","id":"PMC_32948209","title":"Expression of the pacemaker channel HCN4 in excitatory interneurons in the dorsal horn of the murine spinal cord.","date":"2020","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/32948209","citation_count":5,"is_preprint":false},{"pmid":"36332467","id":"PMC_36332467","title":"Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients caused by heterozygous mutations in the HCN4 gene.","date":"2022","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36332467","citation_count":5,"is_preprint":false},{"pmid":"37760888","id":"PMC_37760888","title":"The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data.","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/37760888","citation_count":5,"is_preprint":false},{"pmid":"39045008","id":"PMC_39045008","title":"Stem cell-derived cardiomyocytes expressing a dominant negative pacemaker HCN4 channel do not reduce the risk of graft-related arrhythmias.","date":"2024","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39045008","citation_count":5,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53805,"output_tokens":9209,"usd":0.149775},"stage2":{"model":"claude-opus-4-6","input_tokens":13062,"output_tokens":5498,"usd":0.30414},"total_usd":0.453915,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"Cardiac-specific inducible knockout of HCN4 in adult mice causes ~70% reduction in If current and ~60% reduction in spontaneous sinoatrial node rate, leading to severe bradycardia (~50% rate reduction), AV block, and death, demonstrating that HCN4 channels are essential for normal cardiac impulse generation and conduction.\",\n      \"method\": \"Inducible cardiac-specific knockout mouse model, patch-clamp electrophysiology on isolated SAN myocytes, immunofluorescence, Western blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — clean cardiac-specific KO with defined electrophysiological and phenotypic readouts, multiple orthogonal methods\",\n      \"pmids\": [\"21220308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HCN4 and HCN1 co-assemble into heteromeric channels in the rabbit sinoatrial node; HCN4-HCN1 tandem constructs show intermediate activation kinetics between the two homomeric channels, suggesting native If reflects heteromeric HCN4/HCN1 channels with properties distinct from either isoform alone.\",\n      \"method\": \"Heterologous expression in HEK293 cells, patch-clamp electrophysiology, concatenated tandem constructs, co-transfection\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution of heteromeric channels with functional validation; replicated across multiple construct designs\",\n      \"pmids\": [\"12702747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HCN1 and HCN4 are expressed in a subset of taste receptor cells; lowering extracellular pH causes a dose-dependent depolarizing shift in the activation curve of HCN channels, indicating that HCN4 channels are gated by extracellular protons and may function as sour taste receptors.\",\n      \"method\": \"In situ hybridization, immunohistochemistry, patch-clamp electrophysiology on taste cells, pH dose-response\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct electrophysiological recordings with pH manipulation, replicated with immunohistochemistry and in situ hybridization\",\n      \"pmids\": [\"11675786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The D553N missense mutation in HCN4 causes a trafficking defect that reduces membrane expression of the channel in a dominant-negative manner, resulting in decreased If current and sinus node dysfunction.\",\n      \"method\": \"Heterologous expression in HEK293 cells, patch-clamp electrophysiology, Western blot, trafficking assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional expression with dominant-negative co-expression, trafficking assay, multiple methods in a single study\",\n      \"pmids\": [\"15123648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"KCNE2 specifically co-assembles with HCN4 (but not other KCNE family members) via interaction of its C-terminal tail with the C-terminal tail of HCN4, enhancing current amplitude and slowing activation kinetics of HCN4 channels.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes and CHO cells, two-electrode voltage-clamp, patch-clamp, yeast two-hybrid assay\",\n      \"journal\": \"Pflugers Archiv : European journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional co-expression combined with yeast two-hybrid protein interaction, specific isoform selectivity demonstrated\",\n      \"pmids\": [\"12856183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The crystal structure of the C-terminal fragment of human HCN4 (C-linker + CNBD) at 2.4 Å reveals high overall similarity to mouse HCN2 but shows a ~3-fold reduced response to cAMP; residues in the β4-β5 loop region account for isoform differences in cAMP sensitivity. Upon cAMP binding, hHCN4 C-terminal protein exerts a prolonged effect on channel deactivation.\",\n      \"method\": \"X-ray crystallography, biochemistry, patch-clamp electrophysiology, mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis and functional validation in a single study\",\n      \"pmids\": [\"20829353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PKA directly phosphorylates HCN4 at ≥13 sites (identified by in vitro phosphorylation and mass spectrometry), including a regulatory site in the distal C-terminus required for PKA-mediated shift of voltage dependence. PKA inhibition reduces β-adrenergic modulation of If in sinoatrial myocytes, indicating PKA phosphorylation contributes independently to sympathetic regulation of heart rate.\",\n      \"method\": \"In vitro phosphorylation assay, mass spectrometry, patch-clamp on isolated sinoatrial myocytes, HCN4 truncation and alanine-substitution mutants in HEK cells\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro phosphorylation + MS site identification + mutagenesis + native cell electrophysiology in one study\",\n      \"pmids\": [\"20713547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The G480R mutation in the HCN4 pore domain causes familial sinus bradycardia by activating channels at more negative voltages and reducing channel synthesis and plasma membrane trafficking, demonstrated by biotinylation and Western blot.\",\n      \"method\": \"Expression in Xenopus oocytes and HEK293 cells, patch-clamp, biotinylation assay, Western blot\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (electrophysiology + trafficking/biotinylation) in single study\",\n      \"pmids\": [\"17646576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Residues in transmembrane segments S1, the S1-S2 linker, and S2 of HCN4 determine its slow activation kinetics relative to HCN2; L272 in S1 is the dominant determinant, and I308M in S2 abolishes cAMP-dependent acceleration of activation kinetics.\",\n      \"method\": \"Chimeric channel analysis (HCN2/4 chimeras and point mutants), patch-clamp electrophysiology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with systematic chimera analysis and functional validation\",\n      \"pmids\": [\"12813043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Constitutively active Src tyrosine kinase enhances HCN4 activity (positive voltage shift, accelerated kinetics, increased conductance) and forms a direct protein complex with HCN4, as shown by co-immunoprecipitation in HEK293 cells and rat ventricular myocytes.\",\n      \"method\": \"Co-transfection in HEK293 cells, whole-cell patch-clamp, co-immunoprecipitation\",\n      \"journal\": \"Journal of cardiovascular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP plus functional electrophysiology, single lab\",\n      \"pmids\": [\"16680072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Src tyrosine kinase modulates HCN4 gating primarily through Tyr531; the Y531F mutation abolishes Src-mediated positive voltage shift and conductance increase of HCN4 channels. Tyr554 mediates Src-dependent kinetic changes but not voltage dependence.\",\n      \"method\": \"Selective Src inhibitor (PP2), site-directed mutagenesis, whole-cell patch-clamp in HEK293 cells and HL-1 cardiomyocytes, in vivo mouse heart rate measurement\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis identifying specific tyrosine residues with functional electrophysiological validation\",\n      \"pmids\": [\"17977941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HCN4 contains a conserved caveolin-binding domain (CBD) composed of aromatic residues Y259 and F262 at the N-terminus; disruption of the CBD reduces HCN4 current density, weakens HCN4-caveolin-1 interaction, causes cytoplasmic channel accumulation, and abolishes sensitivity to cholesterol depletion-induced caveolar disorganization.\",\n      \"method\": \"Mutagenesis (Y259S, F262V, Y259F, F262Y), patch-clamp in CHO cells and caveolin-1-free fibroblasts, co-immunoprecipitation\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis + functional electrophysiology + protein interaction, multiple cell types\",\n      \"pmids\": [\"22659290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"β2-adrenergic receptors form a direct protein complex with HCN4 channels; the binding site is located at a proximal region of the HCN4 N-terminal tail. A synthetic peptide from this region disrupts the HCN4-β2AR complex and prevents adrenergic augmentation of If and spontaneous contraction rate, but does not affect adrenergic regulation of voltage-gated calcium currents.\",\n      \"method\": \"Co-immunoprecipitation, synthetic peptide competition, patch-clamp electrophysiology, spontaneous contraction rate measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — Co-IP + peptide disruption + functional electrophysiology, defining binding domain\",\n      \"pmids\": [\"22613709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HCN4 K530N mutation in the C-linker causes tachycardia-bradycardia syndrome and atrial fibrillation; in heteromeric channels (WT+mutant), but not homomeric mutant channels, there is a significant hyperpolarizing shift in half-maximal activation voltage, attributed to altered C-linker oligomerization equilibrium between nucleotide-free and ligand-bound tetrameric states.\",\n      \"method\": \"Patch-clamp electrophysiology in HEK293 cells (homomeric and heteromeric co-expression), pedigree analysis\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — heteromeric co-expression with functional analysis, single lab\",\n      \"pmids\": [\"23178648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cardiac myocardial HCN2 undergoes proteolytic processing in adult mouse heart, losing its C-terminal cAMP-binding domain to yield a ~60 kDa fragment; this C-terminally truncated HCN2 co-assembles with HCN4 to form heteromeric channels that activate faster than homomeric HCN2 or HCN4 and display properties similar to endogenous myocardial If. HCN4 provides the cAMP sensitivity in these complexes.\",\n      \"method\": \"Western blot, co-immunoprecipitation with isoform-specific antibodies from adult mouse heart, heterologous expression of truncated HCN2+HCN4, patch-clamp\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — co-IP from native tissue + reconstituted heteromeric channels + functional electrophysiology\",\n      \"pmids\": [\"19574228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MEF2 (myocyte enhancer factor-2) and AP1 transcription factors directly bind to the CNS13 enhancer in the Hcn4 genomic locus; dominant-negative MEF2 inhibits enhancer activity, reduces Hcn4 mRNA expression, and decreases Ih amplitude in embryonic heart inflow tract myocytes, establishing Hcn4 as a direct MEF2 transcriptional target.\",\n      \"method\": \"Luciferase reporter assay, EMSA, chromatin immunoprecipitation, dominant-negative MEF2 overexpression, patch-clamp in primary neonatal rat cardiomyocytes\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP + EMSA + functional electrophysiology confirming transcriptional mechanism\",\n      \"pmids\": [\"19477969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The NRSE motif in the HCN4 gene promoter binds NRSF (neuron-restrictive silencing factor), and this interaction mediates the developmental silencing of HCN4 after birth and its reactivation during cardiac hypertrophy; mutant NRSE constructs fail to recapitulate developmental expression changes.\",\n      \"method\": \"Promoter-luciferase reporter assay, EMSA confirming NRSF binding, mutation analysis in primary neonatal rat cardiomyocytes\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — EMSA + reporter assay, single lab\",\n      \"pmids\": [\"17173866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HCN4 is a direct target of miR-1 in cardiomyocytes; down-regulation of miR-1 in hypertrophied rat hearts contributes to increased HCN4 protein levels, and forced miR-1 expression prevents HCN4 overexpression in hypertrophic cardiomyocytes.\",\n      \"method\": \"Western blot, RT-PCR, transfection of miR-1 mimics in primary neonatal cardiomyocytes, rat cardiac hypertrophy model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional miRNA over-expression experiments with protein readout, single lab\",\n      \"pmids\": [\"18458081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-423-5p targets the HCN4 3'-UTR and suppresses HCN4 expression; knockdown of miR-423-5p rescues HCN4 expression and If, reversing training-induced bradycardia in swim-trained mice. The upregulation of miR-423-5p and its host gene NSRP1 in the sinus node is driven by increased Nkx2.5.\",\n      \"method\": \"Luciferase 3'-UTR reporter assay, anti-miR knockdown in vivo, next-generation sequencing, qRT-PCR, Western blot, patch-clamp, chromatin immunoprecipitation\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reporter assay + anti-miR in vivo rescue + ChIP + functional electrophysiology, multiple orthogonal methods\",\n      \"pmids\": [\"28821541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The circadian clock transcription factor BMAL1 directly binds to the Hcn4 promoter in sinoatrial node cells, driving 24-hour rhythmicity of HCN4 expression and If. Cardiomyocyte-specific knockout of Bmal1 abolishes the day-night difference in Hcn4 mRNA expression and intrinsic heart rate.\",\n      \"method\": \"Chromatin immunoprecipitation, cardiomyocyte-specific Bmal1 KO transgenic mice, patch-clamp, qRT-PCR, Western blot, telemetric ECG, HCN4 promoter reporter bioluminescence\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP identifying BMAL1 binding + KO rescue + functional electrophysiology, multiple orthogonal methods\",\n      \"pmids\": [\"33278629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mef2C directly activates an Hcn4 enhancer in non-chamber myocardium and the postnatal AV bundle in a Mef2c-dependent manner in vivo; HDAC inhibition expands Hcn4 enhancer activity to working myocardium, and cardiac hypertrophy-induced HDAC nuclear export causes ectopic Hcn4 enhancer activation in working myocardium.\",\n      \"method\": \"Transgenic reporter mice, in vivo cis-regulatory analysis, HDAC inhibitor treatment of transgenic embryos, transverse aortic constriction model\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic enhancer assay + Mef2c dependence + HDAC manipulation, single lab\",\n      \"pmids\": [\"23085412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Mitochondrial thioredoxin-2 (Trx2) maintains HCN4 expression in sinoatrial node cells; its deletion increases mitochondrial ROS, which elevates HDAC4, reduces histone acetylation at the MEF2 binding site of the HCN4 enhancer, and decreases HCN4 transcription, causing sick sinus syndrome.\",\n      \"method\": \"Cardiac conduction system-specific Trx2 KO (Hcn4-CreERT2), chromatin immunoprecipitation, histological analysis, mitochondria-specific ROS scavenger (MitoTEMPO) rescue, ECG telemetry\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conduction system-specific KO + ChIP + pharmacological rescue, multiple orthogonal methods identifying HDAC4-MEF2C pathway\",\n      \"pmids\": [\"31751569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Ectopic HCN4 expression in cortical FCM neurons (driven by mTOR hyperactivation) is sufficient to cause epileptic seizures; increasing intracellular cAMP (which preferentially enhances HCN4 gating) drives repetitive firing selectively in FCM neurons, and blocking HCN4 prevents epilepsy in the mouse model.\",\n      \"method\": \"Mouse FCM model (TSC/FCDII), patch-clamp, cAMP manipulation, HCN4 channel blockade, immunohistochemistry in human resected tissue\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — loss-of-function block prevents epilepsy + gain-of-function cAMP drives firing + validated in human tissue\",\n      \"pmids\": [\"33208499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HCN4 cAMP sensitivity and basal voltage dependence are controlled by multiple channel domains, including the distal C-terminus (residues 719-1012); in CHO cells, ligand-independent relief of autoinhibition occurs for HCN4 but not HCN2, mediated by membrane-associated intracellular factors acting on the distal C-terminus.\",\n      \"method\": \"Patch-clamp in CHO and HEK cells, excised patch recordings, truncation mutants, isoform comparison\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — domain truncation + excised patch ruling out soluble factors + cell-type comparison, single lab\",\n      \"pmids\": [\"23109717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LRMP (Jaw1) and IRAG (Mrvi1/Jaw1L) are ER transmembrane proteins that associate with and modulate HCN4 in an isoform-specific manner: LRMP inhibits cAMP-dependent activation of HCN4 while IRAG causes ligand-independent depolarization of basal voltage dependence. IRAG is highly expressed in mouse sinoatrial node and computer modeling predicts it increases HCN4 current.\",\n      \"method\": \"Co-immunoprecipitation, patch-clamp in HEK and CHO cells, computer modeling, mouse sinoatrial node expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP + isoform-specific functional electrophysiology + native tissue expression + computer modeling, multiple orthogonal methods\",\n      \"pmids\": [\"32647060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Shugoshin-1 directly interacts with HCN4 to promote cell-surface expression and function; the clinical CAID syndrome mutation p.Lys23Glu impairs this interaction, reducing funny-current and causing dysrhythmia in patient-derived iPSC-cardiomyocytes.\",\n      \"method\": \"Co-immunoprecipitation, patch-clamp in neonatal rat ventricular myocytes and iPSC-cardiomyocytes, surface expression assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct protein interaction + functional electrophysiology + patient-derived cells + disease-causing mutation validation\",\n      \"pmids\": [\"33953173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HCN4 channels contain two tissue-specific N-terminal variants arising from different transcription start sites; the brain expresses only one variant while heart expresses both. Three positively charged residues (Arg9, Lys10, Lys22) in the N-terminus contribute to differential channel activation kinetics between variants.\",\n      \"method\": \"Identification of mRNA variants, patch-clamp in HEK293H cells, N-terminal mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis + electrophysiology, single lab, novel splice variant with functional consequence\",\n      \"pmids\": [\"21372143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Human HCN4 exhibits voltage-dependent hysteresis: the activation curve shifts to more depolarized voltages with more hyperpolarized holding potentials. cAMP enhances If and modifies this intrinsic hysteresis. HCN4 accounts for 75% of HCN transcripts in human sinoatrial node.\",\n      \"method\": \"Patch-clamp in HEK293 cells stably expressing hHCN4 (triangular ramp and action potential clamp protocols), qRT-PCR of human SAN tissue\",\n      \"journal\": \"Sheng li xue bao : [Acta physiologica Sinica]\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct electrophysiology with multiple clamp protocols + human SAN qPCR, single lab\",\n      \"pmids\": [\"20179882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HCN4 pacemaker channels attenuate parasympathetic (vagal) responses of the sinoatrial node: HCN4 knockdown enhances parasympathetic-induced sinus pause, while HCN4 overexpression attenuates bradycardia induced by vagus nerve stimulation during β-adrenergic stimulation. β-adrenergic response of the SAN is preserved regardless of HCN4 expression level.\",\n      \"method\": \"Tetracycline-inducible HCN4 overexpression/knockdown transgenic mice, telemetric ECG, vagus nerve stimulation, patch-clamp on isolated pacemaker cells\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reversible gain and loss-of-function transgenics + direct vagus nerve stimulation + patch-clamp, multiple orthogonal readouts\",\n      \"pmids\": [\"29315578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structure of HCN4 in complex with ivabradine at 3 Å resolution shows ivabradine bound inside the open pore; Y507 and I511 on S6 are the key molecular determinants of ivabradine binding to the inner cavity, F510 indirectly contributes by controlling Y507 orientation, and Cys479 in the selectivity filter accelerates the kinetics of block. Molecular dynamics simulations show ivabradine blocks ion permeation by electrostatic repulsion at the selectivity filter.\",\n      \"method\": \"Cryo-EM structure determination, molecular dynamics simulations, electrophysiology\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure at 3 Å + MD simulations identifying blocking mechanism, rigorous structural study\",\n      \"pmids\": [\"38917012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The HCN4 D553N mutation in the C-linker causes a gating defect rather than a primary trafficking defect: D553N channels reach the plasma membrane normally but generate currents with reduced amplitude, likely due to stabilization of a salt bridge important for C-linker gating. cAMP regulation is altered but not sufficient to account for the full loss-of-function.\",\n      \"method\": \"Fluorescence microscopy, FACS surface expression assay, two-electrode voltage-clamp in Xenopus oocytes, patch-clamp in mammalian cells\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple electrophysiological and surface expression methods, revises prior trafficking interpretation\",\n      \"pmids\": [\"23075627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Sp1 is a common transactivator of HCN4 gene transcription; siRNA silencing of Sp1 prevents overexpression of HCN4 in hypertrophic cardiomyocytes, and upregulation of Sp1 underlies pathological re-expression of HCN4 in ventricular hypertrophy.\",\n      \"method\": \"5'-RACE, luciferase reporter assay, qRT-PCR, Western blot, Sp1 siRNA knockdown in primary neonatal rat cardiomyocytes\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — promoter analysis + siRNA knockdown with functional readout, single lab\",\n      \"pmids\": [\"19471099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HCN4 co-localizes and co-immunoprecipitates with caveolin-3 in adult human atrial and ventricular cardiomyocytes; caveolae disruption shifts the voltage dependence of If toward more positive (immature) values in adult cardiomyocytes but not in fetal cardiomyocytes where HCN4-Cav3 co-localization is absent.\",\n      \"method\": \"Co-immunoprecipitation, immunohistochemistry in hESC-CMs and adult/fetal human cardiomyocytes, patch-clamp with caveolae-disrupting agents\",\n      \"journal\": \"Stem cells and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP + functional electrophysiology + developmental stage comparison, single lab\",\n      \"pmids\": [\"23311301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Thy1 (a GPI-anchored protein) co-localizes and co-immunoprecipitates with HCN4 in rat retinal ganglion cells, representing the first reported association of Thy1 with a membrane-spanning ion channel subunit.\",\n      \"method\": \"Co-immunoprecipitation with anti-Thy1 and anti-HCN4 antibodies, immunohistochemistry, confocal imaging, patch-clamp on immunopanned cells\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reciprocal Co-IP + electrophysiology, single lab\",\n      \"pmids\": [\"22281825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A gain-of-function HCN4 mutation V240M located in the N-terminal HCN domain increases single-channel conductance, opening frequency, and opening probability without altering cAMP sensitivity or membrane expression, causing inappropriate sinus tachycardia. Computer simulations confirm increased If and beating rate. Treatment with ivabradine reversed IST and cardiomyopathy.\",\n      \"method\": \"Macroscopic and single-channel patch-clamp in cells expressing WT and/or V240M HCN4, computer simulations, clinical ivabradine treatment\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — single-channel recordings + macroscopic currents + computer modeling + clinical validation, multiple orthogonal methods\",\n      \"pmids\": [\"38032931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CVB3 (Coxsackievirus B3) reduces HCN4 plasma membrane density in hiPSC-derived pacemaker cells by triggering increased autophagosomal insertion of HCN4; CVB3 non-structural proteins 2C and 3A have the most robust effect on HCN4 activity. Inhibition of Rab7-directed autophagosome transport (with CID 106770) recovers cytoplasmic HCN4 accumulation.\",\n      \"method\": \"hiPSC-derived pacemaker cells with inducible CVB3 expression, HCN4 trafficking immunofluorescence, patch-clamp, HEK cell HCN4 expression system, Rab7 and CVB3-3A inhibitors\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional viral protein analysis + trafficking assay + pharmacological rescue, single lab\",\n      \"pmids\": [\"35864219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LncRNA RCPCD suppresses HCN4 expression by increasing methylation of the HCN4 promoter through DNMT1, DNMT2, and DNMT3; overexpression of RCPCD inhibits differentiation of embryonic stem cells into pacemaker-like cells, an effect rescued by HCN4 co-expression.\",\n      \"method\": \"Methylation-specific PCR, chromatin immunoprecipitation, RNA immunoprecipitation, luciferase reporter, adenoviral overexpression/knockdown, rescue experiments\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — methylation-specific PCR + ChIP + functional rescue, multiple methods but single lab\",\n      \"pmids\": [\"34215719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Testosterone recruits the androgen receptor (AR) directly to regulatory regions of the HCN4 gene (and MEF2C), increasing histone acetylation and upregulating HCN4 expression and cardiomyogenesis in stem cells.\",\n      \"method\": \"Chromatin immunoprecipitation, AR knockdown/antagonist, dose-response, qRT-PCR, Western blot in mES and P19 cells\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP identifying AR binding at HCN4 locus + loss-of-function knockdown, single lab\",\n      \"pmids\": [\"23598283\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HCN4 is the principal pore-forming subunit of cardiac and neuronal hyperpolarization-activated cyclic nucleotide-gated (If/Ih) channels: it forms homo- or heterotetramers (e.g., with HCN1 or proteolytically processed HCN2) localized in caveolae via a caveolin-binding domain, is gated by membrane hyperpolarization and potentiated by direct cAMP binding to its C-terminal CNBD (with the C-linker controlling gating), is additionally phosphorylated by PKA at ≥13 sites (including a distal C-terminal regulatory site) to mediate β-adrenergic rate acceleration, is further modulated by Src kinase phosphorylation (at Tyr531), forms signaling complexes with β2-adrenergic receptors (via the N-terminal tail), LRMP, IRAG, and Shugoshin-1, and its transcription is directly controlled by MEF2, NRSF, Sp1, BMAL1 (circadian clock), HDAC4, miR-1, and miR-423-5p, with ivabradine blocking the open pore at Y507/I511 on S6 as revealed by cryo-EM.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HCN4 is the principal pore-forming subunit of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels that generate the cardiac pacemaker current (If/Ih), and it is essential for sinoatrial node automaticity, atrioventricular conduction, and autonomic heart rate regulation. HCN4 forms homotetramers or heterotetramers with HCN1 or proteolytically processed HCN2, is gated by membrane hyperpolarization with kinetics determined by S1–S2 transmembrane residues (notably L272), and is potentiated by direct cAMP binding to its C-terminal CNBD—whose isoform-specific sensitivity is set by the β4–β5 loop—while PKA phosphorylation at ≥13 sites and Src kinase phosphorylation at Tyr531 provide additional sympathetic modulation [PMID:20829353, PMID:20713547, PMID:17977941, PMID:12813043]. Channel surface expression requires a caveolin-binding domain (Y259/F262) that targets HCN4 to caveolae, and is further regulated by protein partners including β2-adrenergic receptors (via the N-terminal tail), LRMP, IRAG, and Shugoshin-1, while transcription is controlled by MEF2, NRSF, Sp1, BMAL1 (circadian rhythmicity), HDAC4, miR-1, and miR-423-5p [PMID:22659290, PMID:22613709, PMID:32647060, PMID:33953173, PMID:19477969, PMID:33278629, PMID:28821541]. Loss-of-function mutations (e.g., D553N, G480R) cause familial sinus bradycardia and sick sinus syndrome, while the gain-of-function V240M mutation causes inappropriate sinus tachycardia treatable with ivabradine, which blocks the open pore at Y507/I511 on S6 as revealed by cryo-EM [PMID:15123648, PMID:17646576, PMID:38032931, PMID:38917012].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating that HCN4 channels in taste receptor cells are gated by extracellular protons expanded HCN4 function beyond cardiac pacemaking to sensory transduction.\",\n      \"evidence\": \"Patch-clamp on taste cells with pH manipulation, in situ hybridization and immunohistochemistry\",\n      \"pmids\": [\"11675786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HCN4 is required for sour taste in vivo was not tested\", \"Contribution relative to other acid-sensing channels in taste cells unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing that HCN4 co-assembles with HCN1 into heteromeric channels with intermediate kinetics resolved how native If properties differ from any single HCN isoform.\",\n      \"evidence\": \"Tandem concatenated HCN4-HCN1 constructs and co-transfection in HEK293 cells with patch-clamp\",\n      \"pmids\": [\"12702747\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of native heteromeric channels in SAN not determined\", \"Whether other HCN isoforms participate in native complexes unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Chimeric HCN2/HCN4 analysis identified L272 in S1 and I308 in S2 as determinants of HCN4's characteristically slow activation and cAMP-dependent kinetic modulation, localizing gating control to the voltage-sensor domain.\",\n      \"evidence\": \"Systematic chimera and point-mutant electrophysiology in heterologous cells\",\n      \"pmids\": [\"12813043\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of how L272 slows gating not resolved\", \"Interaction between S1-S2 region and C-linker/CNBD gating not addressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying KCNE2 as a specific auxiliary subunit of HCN4 that enhances current amplitude and slows kinetics revealed a β-subunit modulation mechanism for pacemaker channels.\",\n      \"evidence\": \"Co-expression in oocytes and CHO cells, yeast two-hybrid mapping interaction to C-terminal tails\",\n      \"pmids\": [\"12856183\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of KCNE2-HCN4 interaction in SAN not demonstrated\", \"Whether KCNE2 participates in native heteromeric HCN4/HCN1 channels unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The D553N mutation was initially shown to cause dominant-negative trafficking failure, establishing the first disease mechanism for HCN4 channelopathy causing sinus node dysfunction.\",\n      \"evidence\": \"Trafficking and electrophysiology assays in HEK293 cells with WT/mutant co-expression\",\n      \"pmids\": [\"15123648\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Later work (PMID:23075627) revised the mechanism to a gating defect rather than trafficking failure\", \"No in vivo knock-in model\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that NRSF binds the HCN4 promoter NRSE motif explained the developmental silencing of HCN4 after birth and its pathological re-expression during cardiac hypertrophy.\",\n      \"evidence\": \"EMSA and luciferase reporter assays with NRSE mutations in neonatal rat cardiomyocytes\",\n      \"pmids\": [\"17173866\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No ChIP confirmation of NRSF binding in vivo\", \"Mechanism of NRSF de-repression in hypertrophy not fully defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Src kinase was identified as a direct modulator of HCN4, forming a protein complex and enhancing channel activity, adding tyrosine kinase signaling to the regulatory repertoire of pacemaker channels.\",\n      \"evidence\": \"Co-immunoprecipitation and patch-clamp in HEK293 cells and rat ventricular myocytes with constitutively active Src\",\n      \"pmids\": [\"16680072\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific phosphorylation sites not identified in this study\", \"Physiological stimulus activating Src-HCN4 pathway in SAN not established\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mapping Tyr531 as the critical Src phosphosite for voltage-dependent modulation of HCN4, and separately showing G480R causes familial bradycardia via pore-domain trafficking and gating defects, established residue-level mechanisms for kinase regulation and a second disease-causing mutation.\",\n      \"evidence\": \"Y531F mutagenesis with PP2 inhibitor and patch-clamp (PMID:17977941); G480R biotinylation and electrophysiology in oocytes/HEK cells (PMID:17646576)\",\n      \"pmids\": [\"17977941\", \"17646576\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Src phosphorylation of Y531 occurs in native SAN pacemaker cells not confirmed\", \"Structural consequence of G480R on pore architecture unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identifying miR-1 as a direct post-transcriptional repressor of HCN4 linked microRNA dysregulation to arrhythmogenic HCN4 overexpression in cardiac hypertrophy.\",\n      \"evidence\": \"miR-1 mimic transfection preventing HCN4 protein increase in hypertrophic neonatal cardiomyocytes\",\n      \"pmids\": [\"18458081\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct 3′-UTR targeting by miR-1 not validated by reporter assay in this study\", \"In vivo rescue with miR-1 not performed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Three discoveries converged to define transcriptional and heterotetrameric control: MEF2 directly activates HCN4 transcription via the CNS13 enhancer, Sp1 drives pathological HCN4 re-expression in hypertrophy, and proteolytically processed HCN2 co-assembles with HCN4 providing the cAMP sensor in native cardiac If.\",\n      \"evidence\": \"ChIP/EMSA/dominant-negative MEF2 in cardiomyocytes (PMID:19477969); Sp1 siRNA in hypertrophic cardiomyocytes (PMID:19471099); Co-IP from native heart tissue + reconstituted truncated-HCN2/HCN4 heteromers (PMID:19574228)\",\n      \"pmids\": [\"19477969\", \"19471099\", \"19574228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HCN2 proteolysis occurs in human heart not shown\", \"Integration of MEF2 and Sp1 transcriptional pathways not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The crystal structure of the HCN4 C-linker/CNBD revealed that the β4–β5 loop accounts for HCN4's reduced cAMP sensitivity relative to HCN2, while PKA phosphoproteomics identified ≥13 sites including a distal C-terminal site required for β-adrenergic If modulation, establishing dual (direct cAMP + PKA phosphorylation) sympathetic control.\",\n      \"evidence\": \"2.4 Å X-ray crystallography with mutagenesis (PMID:20829353); in vitro phosphorylation/MS + SAN patch-clamp with PKA inhibition (PMID:20713547)\",\n      \"pmids\": [\"20829353\", \"20713547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length HCN4 structure not available at this time\", \"How PKA phosphorylation and cAMP binding interact allosterically within the tetramer not resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Cardiac-specific HCN4 knockout proved the channel is essential for normal impulse generation, causing ~50% rate reduction, AV block, and lethality, definitively establishing HCN4 as the dominant If contributor in the adult heart.\",\n      \"evidence\": \"Inducible cardiac-specific KO mice with SAN patch-clamp and ECG\",\n      \"pmids\": [\"21220308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of HCN4 loss-of-function to SAN arrest versus AV block not fully dissected\", \"Whether residual If in KO reflects HCN1 or HCN2 contribution not determined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Multiple discoveries defined the macromolecular signaling complex: HCN4 localizes to caveolae via Y259/F262, β2-adrenergic receptors bind the HCN4 N-terminal tail to enable local adrenergic modulation, and Mef2c/HDAC-dependent enhancer regulation controls tissue-specific HCN4 expression.\",\n      \"evidence\": \"Caveolin-binding domain mutagenesis + Co-IP (PMID:22659290); β2AR-HCN4 Co-IP + peptide disruption (PMID:22613709); transgenic enhancer mice + HDAC inhibitor (PMID:23085412)\",\n      \"pmids\": [\"22659290\", \"22613709\", \"23085412\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether β2AR-HCN4 complex exists in native SAN tissue not shown by Co-IP from tissue\", \"HDAC isoform specificity in enhancer regulation not fully resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The D553N mechanism was revised from trafficking defect to C-linker gating defect, and the K530N C-linker mutation was linked to tachycardia-bradycardia syndrome, establishing the C-linker as a critical disease-relevant gating element.\",\n      \"evidence\": \"Surface expression assays showing normal D553N trafficking (PMID:23075627); heteromeric WT+K530N electrophysiology and pedigree (PMID:23178648)\",\n      \"pmids\": [\"23075627\", \"23178648\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural data on how D553N or K530N alter C-linker conformation\", \"K530N heteromeric mechanism based on single-family pedigree\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"miR-423-5p was identified as a physiological repressor of HCN4 in the SAN, mediating exercise-induced bradycardia through an Nkx2.5-driven pathway, with in vivo anti-miR rescue restoring HCN4 and heart rate.\",\n      \"evidence\": \"3′-UTR reporter + anti-miR in swim-trained mice + ChIP for Nkx2.5 + patch-clamp\",\n      \"pmids\": [\"28821541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term effects of anti-miR-423-5p on cardiac function not assessed\", \"Whether this pathway operates in human athletes unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Bidirectional transgenic experiments showed HCN4 primarily buffers parasympathetic (vagal) slowing of heart rate rather than mediating sympathetic acceleration, reframing the physiological role of If in autonomic regulation.\",\n      \"evidence\": \"Inducible HCN4 overexpression/knockdown mice with vagus nerve stimulation and telemetric ECG\",\n      \"pmids\": [\"29315578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether vagal buffering is the dominant in vivo role during all physiological states not tested\", \"Contribution of other ion channels to this vagal buffering not excluded\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The Trx2-ROS-HDAC4-MEF2 axis was identified as a redox-sensitive pathway controlling HCN4 transcription: mitochondrial ROS elevation activates HDAC4 to suppress MEF2-dependent HCN4 enhancer, causing sick sinus syndrome.\",\n      \"evidence\": \"Conduction system-specific Trx2 KO mice, ChIP, MitoTEMPO rescue, ECG telemetry\",\n      \"pmids\": [\"31751569\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this redox pathway operates in human SAN disease not established\", \"Direct HDAC4 phosphorylation/activation mechanism by ROS not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"LRMP and IRAG were identified as ER-tethered, isoform-specific modulators of HCN4—LRMP inhibiting cAMP-dependent gating and IRAG causing ligand-independent voltage shift—while BMAL1 was shown to directly drive circadian HCN4 transcription in the SAN.\",\n      \"evidence\": \"Co-IP + patch-clamp for LRMP/IRAG (PMID:32647060); ChIP + Bmal1 cardiomyocyte-KO + promoter bioluminescence (PMID:33278629)\",\n      \"pmids\": [\"32647060\", \"33278629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ER-resident LRMP/IRAG access plasma membrane HCN4 mechanistically unclear\", \"Whether BMAL1 rhythmicity is disrupted in human SAN disease not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Ectopic HCN4 expression driven by mTOR hyperactivation was shown sufficient to cause epileptic seizures in cortical malformation neurons, establishing a pathogenic neuronal role for HCN4 outside the heart.\",\n      \"evidence\": \"Mouse FCM model with HCN4 blockade preventing seizures, validated in resected human tissue\",\n      \"pmids\": [\"33208499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HCN4-selective blockers would be effective anti-epileptic drugs in humans not tested\", \"Mechanism of mTOR-driven HCN4 transcription not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Shugoshin-1 was identified as a trafficking partner of HCN4, with the CAID syndrome mutation impairing this interaction and reducing If in patient iPSC-cardiomyocytes, linking a mitotic regulator to pacemaker channel surface expression.\",\n      \"evidence\": \"Co-IP, surface expression assay, patch-clamp in iPSC-CMs carrying the SGO1 K23E mutation\",\n      \"pmids\": [\"33953173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of SGO1-HCN4 interaction unknown\", \"Whether SGO1 regulates HCN4 in SAN tissue in vivo not shown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Single-channel recordings of the V240M gain-of-function mutation showed increased conductance and open probability causing inappropriate sinus tachycardia, the first HCN4 gain-of-function mechanism resolved at single-channel level, with ivabradine providing clinical rescue.\",\n      \"evidence\": \"Single-channel and macroscopic patch-clamp, computer simulations, clinical ivabradine treatment\",\n      \"pmids\": [\"38032931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mechanism by which V240M in the HCN domain increases conductance unknown\", \"Long-term outcomes of ivabradine in HCN4 gain-of-function patients not reported\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The 3 Å cryo-EM structure of HCN4 bound to ivabradine revealed the drug's open-pore binding site at Y507/I511 on S6 and the role of C479 in block kinetics, providing the first near-atomic view of HCN4 pharmacological inhibition.\",\n      \"evidence\": \"Cryo-EM structure determination, molecular dynamics simulations, electrophysiology with pore mutants\",\n      \"pmids\": [\"38917012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure in the closed or cAMP-free state not yet reported\", \"Whether ivabradine binding differs in heteromeric HCN4/HCN1 channels unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A full-length, state-resolved structural model of HCN4 in its resting, open, and cAMP-bound conformations—particularly in heteromeric complexes with HCN1—remains unavailable, limiting mechanistic understanding of voltage-dependent gating, hysteresis, and allosteric coupling between the CNBD, C-linker, and voltage sensor.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length structure of HCN4 in the closed/resting state\", \"Heteromeric HCN4/HCN1 channel architecture not structurally resolved\", \"Integration of PKA phosphorylation, Src phosphorylation, and cAMP binding within the native tetramer not mechanistically modeled\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 5, 6, 8, 27, 29]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [2, 5, 27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 7, 11, 25, 29, 32, 34]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009909396\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 9, 10, 12, 28]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 22]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [15, 16, 18, 19, 20, 31]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 3, 7, 13, 34]}\n    ],\n    \"complexes\": [\n      \"HCN4/HCN1 heterotetramer\",\n      \"HCN4/HCN2 heterotetramer\",\n      \"HCN4-β2AR signaling complex\"\n    ],\n    \"partners\": [\n      \"HCN1\",\n      \"HCN2\",\n      \"KCNE2\",\n      \"CAV1\",\n      \"CAV3\",\n      \"ADRB2\",\n      \"LRMP\",\n      \"SGO1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}